We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
(+14%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$157M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$117M |
| 3 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$63.3M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$32.3M |
| 3 |
Schwab US REIT ETF
SCHH
|
+$21.3M |
| 4 |
Vanguard Energy ETF
VDE
|
+$18.8M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.74% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 2.19% |
| 4 | Energy | 2.03% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Fidelity National Financial
FNF
$13.9B
| $746K | ﹤0.01% |
21,227
+1,871
| +10% | +$62.7K |
|
|
ACIA
852
DELISTED
Acacia Communications Inc
ACIA
| $746K | ﹤0.01% |
13,006
+200
| +2% | +$9.56K |
|
|
SMC
853
Summit Midstream
SMC
$421M
| $742K | ﹤0.01% |
5,087
+2,734
| +116% | +$481K |
|
|
WCG
854
DELISTED
Wellcare Health Plans, Inc.
WCG
| $741K | ﹤0.01% |
2,746
+907
| +49% | +$234K |
|
855
Dentsply Sirona
XRAY
$2.59B
| $740K | ﹤0.01% |
14,919
-995
| -6% | -$43.8K |
|
856
Toro Company
TTC
$8.93B
| $736K | ﹤0.01% |
10,685
+6,771
| +173% | +$430K |
|
857
Vertex Pharmaceuticals
VRTX
$121B
| $734K | ﹤0.01% |
3,991
-261
| -6% | -$48.2K |
|
858
iShares US Energy ETF
IYE
$1.74B
| $731K | ﹤0.01% |
20,288
-3,167
| -14% | -$111K |
|
859
Live Nation Entertainment
LYV
$41.2B
| $731K | ﹤0.01% |
11,512
-23
| -0.2% | -$1.3K |
|
860
Pool Corp
POOL
$6.7B
| $724K | ﹤0.01% |
4,391
+39
| +0.9% | +$6.05K |
|
861
Teleflex
TFX
$5.85B
| $724K | ﹤0.01% |
2,396
-1,677
| -41% | -$467K |
|
862
Allogene Therapeutics
ALLO
$601M
| $723K | ﹤0.01% |
25,000
+4,800
| +24% | +$139K |
|
|
S
863
DELISTED
Sprint Corporation
S
| $722K | ﹤0.01% |
127,762
+545
| +0.4% | +$3.38K |
|
864
MGP Ingredients
MGPI
$378M
| $721K | ﹤0.01% |
9,343
| – | – |
|
865
Patterson-UTI
PTEN
$3.87B
| $721K | ﹤0.01% |
51,428
-449
| -0.9% | -$5.89K |
|
866
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
| $721K | ﹤0.01% |
31,165
+555
| +2% | +$12.2K |
|
|
SBR
867
Sabine Royalty Trust
SBR
$1.08B
| $721K | ﹤0.01% |
15,500
-1,100
| -7% | -$47.7K |
|
|
RAVN
868
DELISTED
Raven Industries Inc
RAVN
| $721K | ﹤0.01% |
18,782
+82
| +0.4% | +$3.11K |
|
869
AerCap
AER
$23.9B
| $717K | ﹤0.01% |
15,411
+840
| +6% | +$37.9K |
|
870
Wabtec
WAB
$51.1B
| $717K | ﹤0.01% |
9,726
+6,840
| +237% | +$493K |
|
871
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
| $716K | ﹤0.01% |
28,040
+2,160
| +8% | +$54.6K |
|
872
Infosys
INFY
$45B
| $714K | ﹤0.01% |
65,367
-4,860
| -7% | -$51.4K |
|
873
Ovintiv
OVV
$17.5B
| $713K | ﹤0.01% |
19,694
+9,634
| +96% | +$330K |
|
874
HEICO Corp
HEI
$48.9B
| $711K | ﹤0.01% |
7,494
+25
| +0.3% | +$2.18K |
|
875
Alliance Resource Partners
ARLP
$3.18B
| $709K | ﹤0.01% |
34,804
+3,192
| +10% | +$61.7K |
|
Similar funds
Creative Planning's Q1 2019 Portfolio in Review
As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.
- Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
- Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
- Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
- Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
- Creative Planning opened 217 new positions and closed 175 in Q1 2019.
- Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.
Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.